CI
Income statement / Annual
Last year (2024), Cigna Corporation's total revenue was $247.12 B,
an increase of 26.61% from the previous year.
In 2024, Cigna Corporation's net income was $344.00 M.
See Cigna Corporation,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$247.12 B |
$195.19 B |
$180.03 B |
$174.27 B |
$160.55 B |
$153.74 B |
$48.57 B |
$42.04 B |
$40.01 B |
$37.88 B |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$247.12 B
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
1
|
0
|
0.82
|
0
|
0.8
|
0.8
|
0.43
|
1
|
1
|
1
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$14.84 B
|
$14.37 B
|
$13.11 B
|
$12.79 B
|
$13.66 B
|
$13.32 B
|
$11.14 B
|
$9.83 B
|
$9.75 B
|
$0.00
|
| Other Expenses |
$229.54 B
|
$172.28 B
|
$158.47 B
|
$153.54 B
|
$138.74 B
|
$132.35 B
|
$33.27 B
|
$28.27 B
|
$27.17 B
|
$0.00
|
| Operating Expenses |
$244.38 B
|
$186.65 B
|
$171.58 B
|
$166.33 B
|
$152.40 B
|
$145.67 B
|
$44.41 B
|
$38.10 B
|
$36.92 B
|
$0.00
|
| Cost And Expenses |
$237.70 B
|
$186.65 B
|
$171.58 B
|
$166.33 B
|
$152.40 B
|
$145.67 B
|
$44.41 B
|
$38.10 B
|
$36.92 B
|
$0.00
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$1.44 B
|
$1.45 B
|
$1.23 B
|
$1.21 B
|
$1.44 B
|
$1.68 B
|
$498.00 M
|
$252.00 M
|
$278.00 M
|
$0.00
|
| Depreciation & Amortization |
$2.78 B
|
$3.04 B
|
$2.93 B
|
$2.92 B
|
$2.80 B
|
$3.65 B
|
$695.00 M
|
$566.00 M
|
$590.00 M
|
$585.00 M
|
| EBITDA |
$9.42 B |
$9.57 B |
$12.91 B |
$10.41 B |
$14.48 B |
$10.92 B |
$4.08 B |
$4.19 B |
$3.47 B |
$38.30 B |
| EBITDA Ratio |
0.04
|
0.05
|
0.07
|
0.06
|
0.07
|
-0.6
|
0.1
|
0.11
|
0.09
|
0.1
|
| Operating Income Ratio |
0.04
|
0.04
|
0.05
|
0.05
|
0.05
|
-0.63
|
0.08
|
0.1
|
0.08
|
0.09
|
| Total Other Income/Expenses Net |
-$4.15 B
|
-$3.02 B
|
-$53.00 M
|
-$1.15 B
|
$2.72 B
|
-$1.51 B
|
-$579.00 M
|
-$336.00 M
|
-$109.00 M
|
-$34.55 B
|
| Income Before Tax |
$5.27 B
|
$5.51 B
|
$8.40 B
|
$6.79 B
|
$10.87 B
|
$6.57 B
|
$3.58 B
|
$3.61 B
|
$2.98 B
|
$3.33 B
|
| Income Before Tax Ratio |
0.02
|
0.03
|
0.05
|
0.04
|
0.07
|
0.04
|
0.07
|
0.09
|
0.08
|
0.09
|
| Income Tax Expense |
$4.93 B
|
$141.00 M
|
$1.62 B
|
$1.37 B
|
$2.38 B
|
$1.45 B
|
$935.00 M
|
$1.37 B
|
$1.14 B
|
$1.25 B
|
| Net Income |
$344.00 M
|
$5.16 B
|
$6.70 B
|
$5.37 B
|
$8.46 B
|
$5.10 B
|
$2.64 B
|
$2.24 B
|
$1.87 B
|
$2.09 B
|
| Net Income Ratio |
0
|
0.03
|
0.04
|
0.03
|
0.05
|
0.03
|
0.05
|
0.05
|
0.05
|
0.06
|
| EPS |
1.22 |
17.57 |
21.66 |
15.89 |
23.17 |
13.58 |
10.69 |
8.92 |
7.31 |
8.17 |
| EPS Diluted |
1.22 |
17.39 |
21.3 |
15.75 |
22.96 |
13.44 |
10.54 |
9.17 |
7.19 |
8.04 |
| Weighted Average Shares Out |
$281.40 M
|
$293.89 M
|
$313.07 M
|
$337.96 M
|
$364.98 M
|
$375.92 M
|
$246.65 M
|
$243.97 M
|
$255.36 M
|
$256.15 M
|
| Weighted Average Shares Out Diluted |
$281.40 M
|
$296.88 M
|
$313.07 M
|
$340.97 M
|
$368.39 M
|
$379.82 M
|
$246.65 M
|
$243.97 M
|
$259.65 M
|
$260.59 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
